Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 812 results for "bristol myers squibb"

HC Stocks Overview: AbbVie Inc (NYSE:ABBV), Bristol-Myers Squibb Co (NYSE:BMY)
Share Market Updates

Bristol-Myers Squibb's Opdivo (nivolumab) Receives Breakthroug...

PRINCETON, N.J.--( BUSINESS WIRE )-- Bristol-Myers Squibb Company (NYSE:BMY) announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to Opdivo for the potential indication of unresectable locally ... Business Wire, 21 hours ago
Therapy Among Horses and Hay Supply and Demand Chain Executive, 2 hours ago

91 images for bristol myers squibb

Nasdaq, 3 days ago
PharmaVOICE, 2 weeks ago
Jutia Group, 3 days ago
Reuters India, 1 week ago
FiercePharma, 2 weeks ago
Jutia Group, 2 weeks ago
Jutia Group, 1 week ago
4 Traders, 2 weeks ago
Octafinance, 1 month ago
Schaeffers Research, 17 hours ago

BMS nabs a sixth breakthrough tag for Opdivo in bladder cancer

Bristol-Myers Squibb claims to have sewed up more than 80% of the U.S. and other major markets share of PD-1 spending with its Opdivo. Now, it's moving ahead with its latest Breakthrough Therapy Designation, the sixth that the FDA has given for the ...
 FierceBiotech16 hours ago Bristol-Myers Squibb's bladder cancer treatment granted breakthrough therapy designation  TD Ameritrade21 hours ago Bristol nabs Opdivo 'breakthrough' in bladder cancer  FiercePharma14 hours ago Could Merck Beat Bristol-Myers To Market?  Seeking Alpha1 week ago

Global HCV Market: Gilead Sciences, AbbVie, J&J and Bristol-Myers Squibb Featured in 2016 Hepatitis C Virus Edition Report

Comments PUNE, India, March 30, 2016 /PRNewswire/ -- As per a new report, "Hepatitis C Virus Market: 2016 Edition," the demand for HCV will be driven by comfort of reimbursement, growth in the number of patients, smaller period of drug treatment, ...
 AndhraNews.net1 week ago Geriatric Medicines Market Analysis, Development, Growth and Demand Forecast to 2023  MyNewsDesk1 hour ago Global Prostate Cancer Therapeutics Industry  BioSpace13 hours ago New Market Research Report: Lysophosphatidic Acid Receptor 1 - Pipeline Review, H1 2016  Digital Journal3 days ago


Reuters is the news and media division of Thomson Reuters . Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news ...
 Reuters UK5 days ago
Motley Fool

3 Ways This $30 Billion Market Is Bristol's for the Taking

Image source: Bristol-Myers Squibb. Just three years ago, Bristol-Myers Squibb ( NYSE:BMY ) took a huge gamble selling its diabetes unit in a $4 billion deal to refocus its efforts on immuno-oncology (or "I-O" for short), a novel approach aimed ...
 Motley Fool6 days ago
Reuters India

NICE Recommends BMS's Melanoma Combination Treatment

The UK's drug pricing watchdog is recommending reimbursement of Bristol-Myers Squibb's melanoma combination treatment of Opdivo and Yervoy, provided the company discounts the latter. In a final appraisal, UK's National Institute for Health and ...
 FDA News3 days ago NICE greenlights Bristol-Myers' combo drug for melanoma  BioPharma Dive1 week ago Bristol's Opdivo-Yervoy melanoma combo wins speedy thumbs up from NICE  FiercePharma1 week ago UK cost agency speeds approval of Bristol melanoma drug cocktail  London South East1 week ago
Nasdaq featured highlights: B&G Foods, J. M. Smucker, Bristol-Myers Squibb, Pretium Resources and FTI Consulting

For Immediate Release Chicago, IL June 17, 2016 - Stocks in this week's article include: B&G Foods Inc. ( BGS ), J. M. Smucker Company ( SJM ), Bristol-Myers Squibb Company ( BMY ), Pretium Resources Inc. ( PVG ) and FTI Consulting Inc. ( FCN ...
 Yahoo! Singapore1 week ago

Two Indian generics makers end battle to copy drugs

Two Indian drugmakers said they had given up a battle to copy drugs developed by Bristol Myers Squibb and AstraZeneca, blaming a lack of government support for inexpensive generics and pressure from ...
 The Hindu2 months ago Two generics makers end battle to copy drugs amid patent debate  Economic Times2 months ago RPT-Two Indian generics makers end battle to copy drugs amid patent debate  Sify2 months ago

Bristol-Myers Squibb Foundation Awards MMC $5M for Sustainable Lung Cancer Prevention and Screening in Maine

/3BL Media/— The Bristol-Myers Squibb Foundation has awarded a$5 million grant to Maine Medical Center (MMC) for the creation of a statewideinitiative to improve the prevention, early detection and treatment of lung cancer inMaine, where incidence ...
 Justmeans19 hours ago

Bristol-Myers Squibb's Miracle Drug Opdivo Receives Yet Another Breakthrough Designation

By Mark Terry , Breaking News Staff Princeton, New Jersey - Bristol-Myers Squibb ( BMY ) announced today that its drug Opdivo had been granted Breakthrough Therapy Designation by the U.S. Food and Drug Administration (FDA) for the ...
 BioSpace18 hours ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - bristol myers squibb
Get updated on latest news & your favorite topics right in your inbox!
More     Less